Recombinant Vector BiP Fragment Minimization Foreign Peptide Sequences

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant proteins face challenges in increasing production amounts and enhancing stability, particularly due to the addition of foreign peptide sequences during protein preparation, which can affect the efficacy and safety of biopharmaceuticals.

Innovation Solution

A recombinant vector is developed that includes a new BiP gene fragment, allowing for the sequential linkage of a polynucleotide encoding a target protein to minimize foreign peptide sequences and enhance expression levels, using promoters like 35S from cauliflower mosaic virus and transgenic organisms such as plants for protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to produce recombinant proteins, then production can be achieved, but the production amount is limited and foreign peptide sequences are added during preparation

Engineering Contradiction:
Improveproduction amount of recombinant proteinVSAvoidpurity of recombinant protein (presence of foreign peptide sequences)
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention extracts and utilizes the BiP fragment (amino acids 1-240) from the endoplasmic reticulum, which naturally binds to recombinant proteins during their secretory pathway. By incorporating this fragment into the expression system, the foreign peptide sequences are minimized while maintaining protein production and purification capabilities.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The BiP fragment acts as an intermediary that facilitates the binding and purification of recombinant proteins. It serves as a mediator between the expression system and the target protein, enabling efficient purification through its natural protein-binding properties without requiring extensive foreign peptide tags.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If foreign peptide sequences are added during protein preparation, then purification can be facilitated, but the stability and efficacy of the biopharmaceutical is reduced

Engineering Contradiction:
Improvepurification processVSAvoidstability of recombinant protein
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention extracts only the essential BiP fragment (amino acids 1-240) rather than using full-length BiP or large foreign peptide tags. This minimized foreign sequence approach maintains purification efficacy while reducing the impact on protein stability and efficacy.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the parameter of foreign peptide sequence length by using a truncated BiP fragment (240 amino acids) instead of full-length BiP or conventional large tags. This parameter optimization maintains purification capability while minimizing negative effects on protein stability.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If conventional expression systems are used, then protein production can be achieved, but the use stability of the recombinant protein is reduced

Engineering Contradiction:
Improveexpression level of target proteinVSAvoiduse stability of recombinant protein
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The BiP fragment serves as a beneficial intermediary that is naturally present in the endoplasmic reticulum and binds to recombinant proteins during their secretory pathway. This natural interaction enhances protein stability without requiring large foreign peptide sequences that could interfere with protein function.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS11434496B2Recombinant vector comprising BiP fragment and preparation method of recombinant proteins using thereof
Publication Date: 2022.09.06 BIOAPPLICATIONS INC
  • US11434496B2 patent drawing
  • US11434496B2 patent drawing

AI summary

Provided is a recombinant vector including a new BiP gene fragment, and when a target protein is prepared using the recombinant vector of the subject matter, use stability can be enhanced and the production amount of target protein can also be increased by minimizing a foreign peptide sequence remaining in the target protein.